16Jun
Related Posts
10May
Platelet BioGenesis Licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan
Platelet BioGenesis, a pioneer in the production of functional human platelets (PLTs+™) from stem cells, announced it has licensed patents... read more
03Oct
Platelet Biogenesis and Scaled Biolabs to Collaborate to Optimize Platelet Production Platform
Platelet BioGenesis (PBG), the leader in the production of functional human platelets (PLTs+™) from stem cells and the development of... read more
24Nov
A Wearable Tech Miracle For the Legally Blind
For Conrad Lewis, the founder of eSight, the project is close to the heart. Lewis grew up with two legally... read more
25Apr
ARVO LIVE: eSight Go: Smart glasses for low vision enhancement
Ophthalmology Times® talked with Roland Mattern, Director of Sales and Marketing for eSight and eSight User Gary Foster at this... read more
07Apr
Regroup Presents Live Webinar to Highlight Critical Aspects of Cyber Security for 2017
Regroup Mass Notification, the award-winning leader in emergency and day-to-day mass communication technology, will be presenting an informative webinar to... read more
15Oct
From the bottom of rocks to the halls of Harvard, this CEO has been looking for a new way to feed fish
After founding alternative feed ingredients biotech firm KnipBio in 2013, Larry Feinberg, a baseball loving, mountain biker, says he has... read more
20Oct
Meet The New Unicorns Minted In September 2022
Twelve companies joined The Crunchbase Unicorn Board in September 2022, adding $19.6 billion in value to the board.
These companies have... read more
17Dec
Elizabeth Banks Puts Her Unique Stamp (and Face) on Archer Roose Wine
The deal that Elizabeth Banks has with Archer Roose, a premium canned wine brand, isn’t one of those superficial celebrity... read more
13Nov
Carbonite Inc. (CARB) Breaks into New 52-Week High on November 11 Session
Shares of Carbonite Inc. (CARB) broke into a new 52-week high yesterday, hitting a peak of $17.95. Shares closed at... read more
08Aug
Corbus Pharmaceuticals to Present New Data from Systemic Sclerosis Phase 2 Study of Anabasum at the 15th International Workshop on Scleroderma Research
Corbus Pharmaceuticals Holdings, Inc.(NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory... read more